• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CLARE DISCRETE MFG IO ACCESS INTACT PTH; RADIOIMMUNOASSAY, PARATHYROID HORMONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CLARE DISCRETE MFG IO ACCESS INTACT PTH; RADIOIMMUNOASSAY, PARATHYROID HORMONE Back to Search Results
Model Number A16972
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 10/13/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The full patient identifier is case (b)(4).The customer did not supply patient demographics such as age, date of birth, weight, ethnicity or race.The access pth reagent was not returned for evaluation.No hardware errors, flags or other assay issues were reported in conjunction with this event.No other patient results were called into question.The customer did not report an issue with the sample integrity.As the customer reported that the staff checks the sample to ensure it is within 24 hours from booking in, it was recommended to customer to follow the intact pth instructions for use part number a57353 n stating: ¿for serum samples: store samples tightly stoppered at room temperature (15 to 30°c) for no longer than 4 hours.¿ in conclusion, the cause of this event cannot be determined with the available information.There is no evidence to reasonably suggest that a malfunction occurred in conjunction with this event.
 
Event or Problem Description
On (b)(6) 2021 the customer reported one non-repeatable erroneously elevated pth (access intact pth) result had been generated on the customer's unicel dxi 800 immunoassay system (part number 973100 and serial number (b)(4)).The patient¿s pth result obtained on (b)(6) 2021 was high at 114.9 pg/ml and discordant with the patient clinical file (expected values are 12-88 pg/ml).Then the patient¿s supplementation in calcium was stopped on (b)(6) 2021 and the patient was retested twice.The pth results were at 56.8 pg/ml on (b)(6) 2021 and at 39.7 pg/ml on (b)(6) 2021.As the last result was as expected, the treatment was restarted on (b)(6) 2021.The patient had a normal adjusted calcium and renal function and was vitamin d supplemented.The patient is suffering from osteoporosis, the additional patient¿s supplementation in calcium was temporarily stopped by the rheumatologist after the elevated pth result was obtained.The treatment was stopped on (b)(6) 2021 then restarted on (b)(6) 2021.There was no further report of an injury or illness to the patient attributable to the output from the device in this event.No hardware errors or other assay issues were reported in conjunction with this event.System check passed on 8oct2021 and on 19oct2021.Calibration passed on (b)(6) 2021 with reagent lot 172064 and calibrator lot 189735.Qc was passing within the laboratory¿s established ranges at time of the event.No issues with sample integrity were reported by the customer.Per customer verbal's report, samples are booked in on receipt, centrifuged and placed on the automate for sorting before it goes on to the main analyzer.The staff check the sample to ensure it is within 24 hours from booking in.The sample was not hemolyzed.A sarstedt serum gel tube was used to collect the sample, the tube was centrifuged at 3600 rpm for 10 minutes.The clot time is unknown.It is unknown if the tube was completely filled.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS INTACT PTH
Common Device Name
RADIOIMMUNOASSAY, PARATHYROID HORMONE
Manufacturer (Section D)
CLARE DISCRETE MFG IO
lismeehan
o'callaghans mills
EI 
Manufacturer (Section G)
CLARE DISCRETE MFG IO
lismeehan
o'callaghans mills
EI  
Manufacturer Contact
harry long
1000 lake hazeltine drive
chaska, MN 55318
9523681224
MDR Report Key13017280
Report Number9680746-2021-00053
Device Sequence Number4976616
Product Code CEW
UDI-Device Identifier15099590201937
UDI-Public(01)15099590201937(17)220331(11)210331(10)172064
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K061190
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 12/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/31/2022
Device Model NumberA16972
Device Catalogue NumberA16972
Device Lot Number172064
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date12/07/2021
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/07/2021
Initial Report FDA Received Date12/16/2021
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/31/2021
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexFemale
-
-